VYNE Therapeutics Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
VYNE on Nasdaq
Location
685 Route 202/206 N., Suite 301, Bridgewater, NJ

There are no Buy or Sell transactions made by insiders since 11/21/2023

VYNE Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Perceptive Advisors Llc 10%+ Owner $11.3M Aug 16, 2021
AI Biotechnology LLC 10%+ Owner $2.55M Nov 1, 2023
David Domzalski PRESIDENT AND CEO, Director $934K Sep 30, 2024
Mutya Harsch Chief Legal Officer And Gc $280K Sep 30, 2024
Andrew Saik Chief Financial Officer $266K May 28, 2021
Iain Stuart Chief Scientific Officer $251K Sep 30, 2024
Matthew Wiley Chief Commercial Officer $249K Jun 30, 2021
Tyler Zeronda Chief Financial Officer $247K Sep 30, 2024
Patrick G. Lepore Director $83.2K Jan 1, 2024
Christine Borowski Director Jan 1, 2024
Elisabeth Sandoval Director Jan 1, 2024
Steven L. Basta Director Jan 1, 2024
Sharon Barbari Director Jan 1, 2024
Anthony D. Bruno Director Jan 1, 2024
Rex Bright Director Jul 19, 2021

Recent Insider Transactions by Companies or Individuals for VYNE Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.